For Immediate Release

FDA Expert Joins BGR — Remy Brim Bolsters Firm’s Top Health & Lifesciences Team

Washington, D.C. – August 20, 2018: BGR Government Affairs announced today that Remy L. Brim, Ph.D. will join the firm as Vice President for Regulatory Policy and Strategy. Remy is a health care policy expert, having managed the full health care portfolio for an active, high-profile Senate personal office and led the Senate Health, Education, Labor and Pensions (HELP) Committee’s Democratic staff engagement on issues related to the U.S. Food and Drug Administration (FDA). At BGR, she will join the Health and Lifesciences Practice, focusing primarily on strategic policy and advocacy support for clients with FDA-regulated products and activities.

Commenting on the new hire, Dave Boyer, BGR’s Health and Lifesciences Practice Head said, “My colleagues and I had the privilege of working with Remy during her time on Capitol Hill. She’s widely respected for the passion, thoughtfulness and commitment to sound public health policy that she brings to many of the most complicated and important healthcare debates in Washington. Combining her scientific training with her experience leading the HELP Committee’s Democratic FDA legislative activities, Remy adds a unique and deeply substantive perspective to the BGR team’s work on behalf of our health care clients.”

For the past two years, Remy served as Senior FDA Policy Advisor to the Senate HELP Committee’s Ranking Member, Patty Murray (D-WA). In this role, she was lead negotiator and advisor for U.S. Senate Democrats on FDA medical device, prescription drug, biologic, food safety, and cosmetic policy initiatives, among others, including the 21st Century Cures Act and the FDA Reauthorization Act of 2017. She managed FDA-related policy development and relationships for the Ranking Member, both internally with Senate leadership, other Senate offices, and their House counterparts, and externally with the FDA and other governmental organizations, regulated industry companies and trade associations, patient advocacy organizations, and other key stakeholders.

Regarding her decision to leave Capitol Hill and join BGR, Remy stated, “When thinking about my next step, the most important thing to me was the opportunity to remain meaningfully engaged on the health policy issues that matter most to patients and public health. BGR has built an outstanding team of talented, knowledgeable, and accomplished professionals, including several of my former Capitol Hill colleagues. They have a well-deserved reputation of helping their life science clients effectively navigate the complex policy, regulatory, and political landscapes. I’m excited to bring a new perspective to BGR’s Health and Lifesciences Practice - through my scientific background and Senate Democratic experience - to further diversify and deepen the team’s unique capacity to support clients’ efforts to discover, develop and deliver innovative products to patients and consumers.”


For more information/interviews contact:

Loren L. Monroe, Principal, State & Local Practice Head, BGR Government Relations
202-333-4936; lmonroe@bgrdc.com


© BGR Group. All Rights Reserved.